The costs were also unprecedented for the CMS Innovation Center's models, driven primarily due to risk score growth and prescription drug costs that could not be contained by policy modifications.
The costs are "substantial and unmitigable," exceeding $2.3 billion in 2021 and $2.2 billion in 2022, according to the CMS Blog post on...
